Please provide your email address to receive an email when new articles are posted on . In a Healio video exclusive, Edward V. Loftus Jr., MD, discusses the potential of tumor necrosis factor-like ...
Although it is one of the oldest medications used to treat patients with inflammatory bowel disease (IBD) and an effective treatment for an associated arthritis condition called spondyloarthritis (SpA ...
Impact of CAMP Deficiency on Immune Responses and Microbiota in IBD. This illustration depicts the role of Cathelicidin Antimicrobial Peptide (CAMP) in regulating immune responses and microbiota ...
The prevalence of inflammatory bowel disease (IBD) in the United States is approximately 0.9% of the general population, with ulcerative colitis (UC) affecting 0.4% and Crohn’s disease (CD) affecting ...
GOSSELIES, Belgium and NANTES, France, Nov. 12, 2025 /PRNewswire/ -- AbolerIS Pharma ("AbolerIS"), a clinical-stage biopharmaceutical company committed to improving the lives of people suffering from ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback